Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials.
BACKGROUND: Interleukin (IL)-5 is believed to be a key cytokine in eosinophil inflammatory infiltration in asthma. Previous clinical trials have evaluated the efficacy and safety of mepolizumab, a monoclonal antibody against IL-5, in patients with asthma. However, most of these studies were small, t...
Main Authors: | Yao Liu, Song Zhang, Dao-wei Li, Shu-juan Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3609729?pdf=render |
Similar Items
-
Correction: Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials
by: Yao Liu, et al.
Published: (2013-01-01) -
Correction: Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials.
by: Yao Liu, et al.
Published: (2013-01-01) -
Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion
by: Khodr Tello, et al.
Published: (2019-01-01) -
Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome
by: Andrea Matucci, et al.
Published: (2018-05-01) -
Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
by: Steven W. Yancey, et al.
Published: (2019-09-01)